Compare RXT & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RXT | SEER |
|---|---|---|
| Founded | 1998 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 120.0M | 111.4M |
| IPO Year | 2020 | 2020 |
| Metric | RXT | SEER |
|---|---|---|
| Price | $1.92 | $1.76 |
| Analyst Decision | Hold | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $1.71 | N/A |
| AVG Volume (30 Days) | ★ 47.9M | 454.3K |
| Earning Date | 06-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 75.13 | 9.40 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,685,700,000.00 | $16,578,000.00 |
| Revenue This Year | N/A | $2.14 |
| Revenue Next Year | $1.35 | $25.90 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 16.99 |
| 52 Week Low | $0.39 | $1.62 |
| 52 Week High | $2.74 | $2.41 |
| Indicator | RXT | SEER |
|---|---|---|
| Relative Strength Index (RSI) | 58.48 | 40.26 |
| Support Level | $1.13 | $1.71 |
| Resistance Level | $2.74 | $1.97 |
| Average True Range (ATR) | 0.43 | 0.08 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 43.40 | 15.91 |
Rackspace Technology Inc is an end-to-end, hybrid, multi cloud technology services company. It designs, builds and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services; Data; Colocation; Cloud; Managed Hosting; Professional Services; and Security & Compliance. It operates in segments namely, Private Cloud, and Public Cloud. It generates revenue through the sale of consumption-based contracts for its service offerings and from the sale of professional services related to designing and building custom solutions.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.